A new policy analysis led by the Harvard Pilgrim Health Care Institute describes the intensive care crisis in rural America and provides a comprehensive policy solution to bolster intensive care capacity.
Mainz Biomed Announces Financial Half Year Results 2023 and Provides Corporate Update – Biotech Investments
Issuer: Mainz BioMed N.V. / Key word(s): Half Year Results 15.08.2023 / 09:01 CET/CEST The issuer is solely responsible for the content of this announcement.